CN107485706A - A kind of Chinese medicine for treating breast cancer - Google Patents
A kind of Chinese medicine for treating breast cancer Download PDFInfo
- Publication number
- CN107485706A CN107485706A CN201710777529.8A CN201710777529A CN107485706A CN 107485706 A CN107485706 A CN 107485706A CN 201710777529 A CN201710777529 A CN 201710777529A CN 107485706 A CN107485706 A CN 107485706A
- Authority
- CN
- China
- Prior art keywords
- parts
- breast cancer
- chinese medicine
- cancer
- treating breast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Abstract
The invention discloses a kind of Chinese medicine for treating breast cancer, it is made up of the bulk drug of following parts by weight：16 20 parts of celastrus orbiculatus, 16 20 parts of giant knotweed, 59 parts of the root of fangji, 39 parts of turmeric, 20 30 parts of solanum lyratum, 12 parts of the fruit of glossy privet, 6 15 parts of curcuma zedoary, 69 parts of Asian puccoon, 15 30 parts of oldenlandia diffusa, 9 15 parts of Herba Andrographitis, 69 parts of edible tulip, 8 10 parts of mulberry leaf, 69 parts of radix glycyrrhizae, the present invention have the characteristics that therapeutic effect is notable, treatment cycle is short, had no toxic side effect.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicines, more particularly, to a kind of Chinese medicine for treating breast cancer.
Background technology
Breast cancer incidence is in ascendant trend year by year, and especially in China, incidence of disease speedup is twice of the average speedup in the whole world,
Have become the first big cancer killer for threatening women's health.According to the data of China national tumour Register, breast cancer is
The most common cancer of Urban Women, it is the fourth-largest common cancer of rural females.
Traditional therapy has many disadvantages, and operative treatment can be by tumor resection, and still, operation risk is high, performs the operation to people
Body wound is big, makes the reduction of patient's immunity, disease resistance is declined, perform the operation as local treatment means, be only applicable to early stage and
The patient that health is resistant to；Surgery excision can not remove root, can directly result in cancer cell diffusion.
Chemotherapeutics is nearly all cytotoxic drug, while tumour cell is killed, is had to the normal cell of human body
Certain toxic side effect, especially to dividing, breeding, thinner than faster cell such as myeloid element, gastrointestinal tract mucous epithelium
Born of the same parents etc..Chemotherapy can shorten the survival of patients time and Partial tumors are insensitive to medicine, and chemotherapy can not possibly thoroughly kill all in vivo
Cancer cell, cancer cell can also recur or shift within the regular hour.
For radiotherapy while tumour is destroyed, normal tissue cell also can be by certain infringement.Certain histocyte
Tolerance to radioactivity line is that have certain limitation, and irreversible lesion will be produced more than this limitation dosage.Moreover, only pair
Tumour less than 2cm could be destroyed disposably completely, and tumour cell can not possibly be destroyed completely to big tumour radiotherapy line.Radiation
Treatment can not judge the dosage of the effect and adjustment for the treatment of that can not be instant for the treatment of immediately, and the dosage of radiation is by theoretical calculation
To complete, it is difficult to judge whether with being actually consistent, radiotherapy is also possible to reduce the immunity of body in addition, and radiotherapy is normal
As a kind of auxiliary treatment or palliative treatment, once in a while as a kind of essential therapeutic arsenals.
The content of the invention
A kind of Chinese medicine composition for treating breast cancer is provided it is an object of the invention to improve the deficiency of prior art, is had
There is the features such as therapeutic effect is notable, treatment cycle is short, has no toxic side effect.
The invention provides a kind of Chinese medicine for treating breast cancer, it is made up of the bulk drug of following parts by weight：
Celastrus orbiculatus 16-20 parts, giant knotweed 16-20 parts, root of fangji 5-9 parts, turmeric 3-9 parts, solanum lyratum 20-30 parts, fruit of glossy privet 8-16 parts,
It is curcuma zedoary 6-15 parts, Asian puccoon 6-9 parts, oldenlandia diffusa 15-30 parts, Herba Andrographitis 9-15 parts, edible tulip 6-9 parts, mulberry leaf 8-10 parts, sweet
Careless 6-9 parts.
In a preferred embodiment, it is described treatment breast cancer Chinese medicine composition by following parts by weight bulk drug
Composition：
18 parts of celastrus orbiculatus, 18 parts of giant knotweed, 9 parts of the root of fangji, 9 parts of turmeric, 30 parts of solanum lyratum, 12 parts of the fruit of glossy privet, 12 parts of curcuma zedoary, Asian puccoon 9
Part, 30 parts of oldenlandia diffusa, 18 parts of Herba Andrographitis, 9 parts of edible tulip, 10 parts of mulberry leaf, 6 parts of radix glycyrrhizae.
Wherein, celastrus orbiculatus：Bitter, pungent, slightly warm in nature, Return liver, spleen, large intestine channel.Expelling wind and activating blood flow, swelling and pain relieving.Celastrus orbiculatus is total
Terpene has notable cytotoxicity to non-small cell lung cancer, breast cancer, colon cancer, nasopharyngeal carcinoma, glioma, prostate cancer.
Giant knotweed：Mildly bitter flavor, cold nature.Return liver, courage, lung channel.Expelling wind and removing dampness, scattered stasis pain is relieving cough and reducing sputum.With antiviral
And immunoregulation effect.To sarcoma 180, hepatoma, breast cancer, ehrlich ascites cancer, lymphosarcoma, black sarcoma and watt gram cancer, skin
The knurl strain such as skin cancer is effective in cure, and inhibiting rate is all more than 30%.
The root of fangji：Acrid flavour, hardship, it is cold in nature.Return bladder, lung channel.Acted on wind-expelling pain-stopping, inducing diuresis for removing edema.Tet can be with
The DNA for restraining breast cancer cell is synthesized, arresting cell cycle progression, induces the apoptosis of cancer cell.
Turmeric：Acrid flavour, hardship, it is warm-natured.Enter spleen, Liver Channel.Blood-breaking, it is inducing meastruation to relieve menalgia.Contained curcumin can induce breast cancer
Etc. the apoptosis of kinds of tumor cells, and the general Apoptosis for not causing normal structure source.
Solanum lyratum（Bittersweet）：Sweet-bitter flavor, it is cold in nature.It is clearing heat and detoxicating, it is inducing diuresis and reducing edema, it is nonspecific immune that body can be strengthened
Biologically.Clinically it is used for the treatment of the Several Kinds of Malignancy such as stomach cancer, liver cancer, breast cancer.
The fruit of glossy privet：It is sweet, bitter, it is cool in nature.Return liver and kidney channel.Tonify the liver and kidney, clearind deficient heat, can be good at improving body immune
Power, have to kinds of tumor cells and promote apoptosis and inhibited proliferation.
Curcuma zedoary：It is bitter, pungent, it is warm-natured.Enter liver, the spleen channel.Promoting the circulation of qi blood-breaking, Xiao Ji Zhi Tong, to a variety of entity tumor (such as mammary gland
Cancer, lung cancer, liver cancer, colon cancer, carcinoma of endometrium, cervical carcinoma etc.) there are stronger inhibitory action, while cancer cell specific induction of apoptosis.
Asian puccoon：It is sweet, salty, it is cold in nature.Enter percardium, Liver Channel.The effect of with cool blood, activating blood and clearing heat, removing toxic substances.Contained purple
Careless element being capable of inducing mammary cancer cell-apoptosis.
Oldenlandia diffusa：Sweet-bitter flavor, it is cold in nature.Return stomach, large intestine, small intestinl channel.It is clearing heat and detoxicating, inducing diuresis to remove edema, promoting blood circulation and stopping pain.Increase
Add phagocytic activity of leukocytes, humoral immune function can be strengthened.Have to kinds of tumor cells and promote apoptosis and inhibited proliferation.
Edible tulip：Sweet, micro-pungent, it is cool in nature.Return liver, the spleen channel.It is clearing heat and detoxicating, reducing phlegm and resolving masses.To colon cancer（HCT-8）, lung
Cancer（A549）, stomach cancer（BGC-823）, liver cancer（Bel7402）, breast cancer（MCF-7）, oophoroma（A-2780）Cell has non-selection
The toxicity of property moderate strength.Contained colchicin and its derivative colchicinamide has antitumor action in tulip bulb, main to use
It is especially preferable to the effect of breast cancer to treat malignant tumour.
Herba Andrographitis：It is bitter in taste, it is cold in nature.The thoughts of returning home, lung, large intestine, bladder warp.There are clearing heat and detoxicating, anti-inflammatory, swelling and pain relieving effect.Punching
Lotus has inhibitory action to Breast cancer cellular synthesis.
Mulberry leaf：It is bitter, sweet, it is cold in nature.Enter lung, Liver Channel.Dispelling wind and heat from the body, clearing away the lungheat and moisturizing, clear liver and improve vision.Mulberry leaf can give protection against cancer carefully in advance
Born of the same parents generate, and improve body immunity, the transfer ability for weakening tumour is 80.5% to the inhibiting rate of metastases.
Honey-fried licorice root：It is warm-natured, it is sweet.Thoughts of returning home warp, lung channel, stomach, the spleen channel.Invigorate the spleen and benefit qi, clearing heat and detoxicating, expelling phlegm and arresting coughing, delay
Anxious analgesic, coordinating the drug actions of a prescription.There is significant enhancing to natural killer cell activity, there is important regulation to make to body's immunity
With.Play the role of significantly to suppress to human breast cancer cell propagation and induce its apoptosis.
The transfer in breast cancer later stage can occur at many positions, and lung is the most common metastasis site of breast cancer.Be secondly bone,
Pleura, liver, brain, adrenal gland etc., celastrus orbiculatus, edible tulip, curcuma zedoary can induce Increase Apoptosis of Lung Cancer Cells in formula；Solanum lyratum, mountain are kind
Mushroom, curcuma zedoary can be with liver cancer apoptosis reducings；Giant knotweed is to stomach cancer, colon cancer, prostate cancer, leukaemia, oophoroma, skin in formula
Skin cancer and Bone of Breast Cancer transfer cell strain play the role of to induce its apoptosis.Giant knotweed, solanum lyratum, the fruit of glossy privet, oldenlandia diffusa, mulberry
Leaf, radix glycyrrhizae have strengthen immunity effect, can strengthen patient's constitution, so as to strengthen anti-cancer ability.It is thin that mulberry leaf can suppress tumour
The transfer of born of the same parents.The formula can both treat breast cancer, prevention cancer metastasis, can also treat the advanced breast cancer spread
Patient.Honey-fried licorice root is invigorated the spleen and benefited qi, coordinating the drug actions of a prescription.
The present invention is made up of the Chinese herbal medicine of Chinese tradition, according to some principles of differentiation of tcm and modern medicine,
Determined with some compositions, the orderly compatibility for the natural extract that effect is apparent, be combined into cancer cell specific induction of apoptosis with promoting
Its Chinese medicine broken up.
Breast cancer is systemic disease, and a kind of chronic disease, and the present invention can be through the full mistake of breast cancer treatment
Journey, the work(of the existing chemotherapy of this therapy, and it is gentle nontoxic, it is " zero poisons treatment ".Medication for many years, patient without it is any not
Good reaction, tracking blood test is normal, and curative effect does not rebound.In the pure Chinese traditional treatment of 100 advanced breast cancers, survive within 6 years
Rate has exceeded 80%.
This formula has " righting reinforcing, promoting blood circulation and removing blood stasis, eliminating stagnation to stop pain, improving patient's immunity ", with operative treatment phase
With reference to Rehabilitation can be promoted, the recurrence and transfer of prevention of postoperative tumour, Rehabilitation is quickly helped.
The present invention can help patient with advanced cancer to improve symptom, palliate the agonizing sufferings, improve quality of life of patients.For multiple
Hair is shifted and can not carry out doctor trained in Western medicine operation, the patient of chemicotherapy treatment, and by individually taking this formula Chinese medicine, enhancing body is exempted from
Epidemic disease function, Carcinoma cell differentiation and apoptosis are induced, can also have the function that to extend patients ' lives, it could even be possible to being survived with knurl.
Medical expense relative moderate of the present invention, well below the medical expense of doctor trained in Western medicine.
Effect of the prescription of the present invention to breast cancer is to tackle the problem at its root, and three months are a course for the treatment of, typically
One course for the treatment of is taken effect, and three courses for the treatment of are visible to be obviously improved, and six course for the treatment of functions are almost recovered.
Present invention also offers a kind of oral formulations made of the above-mentioned treatment sick Chinese medicine composition, the oral system
Agent includes oral liquid, tablet, capsule, pill etc., and preferred dosage form is oral liquid and capsule, and one one, and point morning and evening is twice
Take.
The Chinese medicine composition of the present invention can be prepared into a variety of formulations.For example, it will be filled after the decoction sterilizing after decoction
Bag, is made oral liquid；Or concentrated the decoction after decoction, after drying, medically receivable auxiliary material is added, is then made
Piece agent, capsule, pill etc..
The medically receivable auxiliary material include starch, dextrin, sodium carboxymethylcellulose, polyethylene glycol, calcium monohydrogen phosphate,
Sodium alginate, potassium sorbate etc..
The animal toxicology experiment summary of Chinese medicine of the present invention：Purpose takes the acute and long term toxicity of the prescription orally for observation rat
Effect.Method：SD rats are study subject, take 4 dosage（40、20、10、5ml/kg）, give decoction and continuously take 540 orally
My god, after the growing of rat during observation administration 90-540 days, blood, blood biochemical and drug withdrawal 30-180 days, rat body weight,
Food ration, activity, peripheral hemogram, important organ coefficient are normal.Toxicological experiment represents：By taking the prescription medication process orally
In, the observation of indices reaction, have no obvious toxic-side effects.Comprehensive analysis thinks：The prescription is under prescribed dose, using being
Safe and reliable.
100 patients are treated using Chinese medicine clinical practice of the present invention, treatment group 100, with the diagnosis and treatment based on an overall analysis of the illness and the patient's condition of this prescription, daily
It is one, decocting 100-150ml, it is divided into two parts, each portion is taken sooner or later, and January is a cycle；Control group 100, using chemotherapy,
It is injected intravenously endoxan, a chemotherapy cycles.No matter total effective rate and obvious effective rate, treatment group is compared with control group, difference
Significantly.Total effective rate treatment group is 97%, control group 70%；Obvious effective rate treatment group is 65%, control group 41%.Following table is treatment
The effect of group is with after control group treatment is evaluated：
The effective enabledisable total effective rate of group number of cases
Treatment group 100 65 32 3 97%
Control group 100 41 29 30 70%。
Specific embodiment
The present invention is described in further detail with reference to embodiment.
Embodiment 1, a kind of Chinese medicine for treating breast cancer, it is by celastrus orbiculatus 16g parts, giant knotweed 20g, root of fangji 5g, turmeric 9g, white
Hair rattan 20g, fruit of glossy privet 16g, curcuma zedoary 6g, Asian puccoon 9g, oldenlandia diffusa 15g, Herba Andrographitis 15g, edible tulip 6g, mulberry leaf 10g, radix glycyrrhizae
6g is formed.
Embodiment 2, a kind of Chinese medicine for treating breast cancer, it is by celastrus orbiculatus 20g, giant knotweed 16g, root of fangji 9g, turmeric 3g, white
Hair rattan 30g, fruit of glossy privet 8g, curcuma zedoary 15g, Asian puccoon 6g, oldenlandia diffusa 30g, Herba Andrographitis 9g, edible tulip 9g, mulberry leaf 8g, radix glycyrrhizae 9g
Composition.
Embodiment 3, a kind of Chinese medicine for treating breast cancer, it is by celastrus orbiculatus 18g, giant knotweed 18g, root of fangji 9g, turmeric 9g, white hair
Rattan 30g, fruit of glossy privet 12g, curcuma zedoary 12g, Asian puccoon 9g, oldenlandia diffusa 30g, Herba Andrographitis 18g, edible tulip 9g, mulberry leaf 10g, radix glycyrrhizae
6g is formed.
Embodiment 4, a kind of Chinese medicine for treating breast cancer, it is by celastrus orbiculatus 18g, giant knotweed 18g, root of fangji 7g, turmeric 6g, white
Hair rattan 25g, fruit of glossy privet 12g, curcuma zedoary 10g, Asian puccoon 8g, oldenlandia diffusa 17g, Herba Andrographitis 12g, edible tulip 8g, mulberry leaf 9g,
Radix glycyrrhizae 8g is formed.
Oral formulations can be made in above-described embodiment, including oral liquid, tablet, capsule, pill etc., preferred dosage form are
Oral liquid and capsule, one one, and a point morning and evening takes twice.
The Chinese medicine composition of the present invention can be prepared into a variety of formulations.For example, it will be filled after the decoction sterilizing after decoction
Bag, is made oral liquid；Or concentrated the decoction after decoction, after drying, medically receivable auxiliary material is added, is then made
Piece agent, capsule, pill etc..
Specific case：
Late certain, female, 36 years old, Longkou, Shandong Province people from city.Left breast is 5.3 × 4.3 centimetres, and matter is hard, true feeling, large stretch of hydroderma " tangerine
Skin sample ", skin temperature rise, obscure boundary are inactive；Left depressed nipple, fixation, extrudable yellowish-brown turbid liquid.On in right breast
4 × the 4cm2 of lump of quadrant one, matter is tough, and boundary is clear, surface is smooth, and activity is good；Right armpit does not touch enlarged lymph node.In 2005
April is descending " left breast cancer improvement radical cure formula Palliative surgery " in general anesthesia.It is postoperative take the course for the treatment of of Chinese medicine 2 of the present invention after, symptom substantially changes
It is kind, it is almost recovered after 6 courses for the treatment of.
Lin, female, 51 years old, Longkou, Shandong Province city Huang Shanguan people from towns.Suffer from breast cancer 08 year resection operation done, diffuses to
Lung, during which body take a favorable turn and just go chemotherapy, go home to recuperate after chemotherapy, waiting to pick body has resistance, then goes chemotherapy.Later
Due in poor health, can only radiotherapy, transfusion.Vomitted always during being in hospital, eat what what tells, maintained, curing by nutrient solution
Institute does not eat for more than 40 days, and stool will also lean on medication, and last one family determines to stop all treatments of hospital, receives Chinese medicine and control
Treat, after taking 3 courses for the treatment of of the invention, symptom is obviously improved, and patient feels that muscle power is being recovered after 6 courses for the treatment of, and the phenomenon of asthma is much better,
Can eat to sleep.
What so-and-so, female, 44 years old, 10 × 8cm2 of the left breast cancer stove of Longkou, Shandong Province city north horse people, 8 × 9cm2 of right breast cancer stove, cancer
Stove position mammary gland changes in orange peel, and both arms activity is difficult, and local pain is serious, loses operation and accuses of.Take Chinese medicine of the present invention
Mass reduction is 4 × 4cm2 of left side after 90 days, and 3 × 2cm2 of right side, freely, pain is relieved for both arms activity, has operation to accuse of,
But patient does not carry out operative treatment because of financial difficulties.Medication six months it is latter as it is all right, have no any metastatic lesion, hereafter
Do not carry out any treatment again, more than 2 years patient's ordinary circumstances of follow-up are good, take care of oneself and are engaged in manual labor.
Claims (4)
- A kind of 1. Chinese medicine for treating breast cancer, it is characterized in that being made up of the bulk drug of following parts by weight：Celastrus orbiculatus 16-20 parts, tiger Cane 16-20 parts, root of fangji 5-9 parts, turmeric 3-9 parts, solanum lyratum 20-30 parts, fruit of glossy privet 8-16 parts, curcuma zedoary 6-15 parts, Asian puccoon 6-9 Part, oldenlandia diffusa 15-30 parts, Herba Andrographitis 9-15 parts, edible tulip 6-9 parts, mulberry leaf 8-10 parts, radix glycyrrhizae 6-9 parts.
- A kind of 2. Chinese medicine for treating breast cancer according to claim 1, it is characterized in that the bulk drug group by following parts by weight Into：18 parts of celastrus orbiculatus, 18 parts of giant knotweed, 9 parts of the root of fangji, 9 parts of turmeric, 30 parts of solanum lyratum, 12 parts of the fruit of glossy privet, 12 parts of curcuma zedoary, Asian puccoon 9 Part, 30 parts of oldenlandia diffusa, 18 parts of Herba Andrographitis, 9 parts of edible tulip, 10 parts of mulberry leaf, 6 parts of radix glycyrrhizae.
- A kind of 3. oral formulations for treating breast cancer, it is characterized in that as the Chinese medicine composition any one of claim 1 or 2 It is made.
- A kind of 4. oral formulations for treating breast cancer according to claim 3, it is characterized in that including oral liquid, tablet, glue Wafer, pill, preferably oral liquid and tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710777529.8A CN107485706A (en) | 2017-09-01 | 2017-09-01 | A kind of Chinese medicine for treating breast cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710777529.8A CN107485706A (en) | 2017-09-01 | 2017-09-01 | A kind of Chinese medicine for treating breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107485706A true CN107485706A (en) | 2017-12-19 |
Family
ID=60646103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710777529.8A Pending CN107485706A (en) | 2017-09-01 | 2017-09-01 | A kind of Chinese medicine for treating breast cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107485706A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1129572A (en) * | 1995-02-20 | 1996-08-28 | 张永亮 | Medicine for curing burn and scald |
| CN1350852A (en) * | 2000-10-30 | 2002-05-29 | 兰州三极生物资源技术公司 | Medicine for treating rheumatic or rheumatoid arthritis, osteoarthropathy and gout |
| CN101947238A (en) * | 2010-06-24 | 2011-01-19 | 攀枝花兴辰钒钛有限公司 | Pharmaceutical composition for treating cancer and application thereof |
| CN104623450A (en) * | 2015-03-16 | 2015-05-20 | 徐若曾 | Traditional Chinese medicine preparation for treating breast cancer |
| CN105999123A (en) * | 2016-07-29 | 2016-10-12 | 王锦生 | Pure traditional Chinese medicine prescription for treating breast cancer and preparation method thereof |
| KR101675930B1 (en) * | 2015-04-02 | 2016-11-14 | 유의순 | Anticancer composition comprising herbal extracts |
-
2017
- 2017-09-01 CN CN201710777529.8A patent/CN107485706A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1129572A (en) * | 1995-02-20 | 1996-08-28 | 张永亮 | Medicine for curing burn and scald |
| CN1350852A (en) * | 2000-10-30 | 2002-05-29 | 兰州三极生物资源技术公司 | Medicine for treating rheumatic or rheumatoid arthritis, osteoarthropathy and gout |
| CN101947238A (en) * | 2010-06-24 | 2011-01-19 | 攀枝花兴辰钒钛有限公司 | Pharmaceutical composition for treating cancer and application thereof |
| CN104623450A (en) * | 2015-03-16 | 2015-05-20 | 徐若曾 | Traditional Chinese medicine preparation for treating breast cancer |
| KR101675930B1 (en) * | 2015-04-02 | 2016-11-14 | 유의순 | Anticancer composition comprising herbal extracts |
| CN105999123A (en) * | 2016-07-29 | 2016-10-12 | 王锦生 | Pure traditional Chinese medicine prescription for treating breast cancer and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 王萍等: "扶正消癌方干预治疗晚期乳腺癌36例临床观察", 《中医药导报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101745065B (en) | Pharmaceutical composition with effects of resisting cancer and alleviating pain | |
| CN102935199A (en) | Chinese medicinal composition for treating chronic gastritis | |
| CN101985028A (en) | Chinese medicinal composition for treating gastritis | |
| CN100593417C (en) | Chinese traditional medicine for treating gastric cancer and bone cancer | |
| CN104524511A (en) | Medicament for treating infantile abdominal distension and pain and preparation method of medicament | |
| CN103301317A (en) | Traditional Chinese medicine composition for treating Spleen deficiency qi collapse haememorrhoids | |
| CN101647961A (en) | Medicament for gastric cancer and esophagus cancer during postoperation and chemotherapy and preparation method thereof | |
| CN104383519A (en) | Chinese and western medicine composition curing stomach cancer and preparation method for Chinese and western medicine composition | |
| CN104623583A (en) | Asthenia cold abdominalgia treating drug and preparation method of asthenia cold abdominalgia treating drug oral liquid | |
| CN107485706A (en) | A kind of Chinese medicine for treating breast cancer | |
| CN100534468C (en) | Orally-administered traditional Chinese medicine for treating irritable bowel syndrome | |
| CN104840902A (en) | Traditional Chinese medicine preparation for treating ovarian tumor | |
| CN103735997B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of gastric cancer | |
| CN102552619B (en) | Medicine for treating tumor and preparation method thereof | |
| CN101940643B (en) | Medicament for treating gastric cancer and esophagus cancer | |
| CN102133358B (en) | Oral administration Chinese medicinal capsules for treating tumors | |
| CN105168745A (en) | Traditional Chinese medicine composition for treating spleen and stomach Qi deficiency type gastric cancer | |
| CN104740013A (en) | Traditional Chinese medicine composition for treating malignant tumors | |
| CN104398954A (en) | Traditional Chinese medicine formula for treating ulcerative colitis | |
| CN105767747A (en) | Crocodile ball food | |
| CN104491613A (en) | Traditional Chinese medicine formula for treating gastrointestinal cancer | |
| CN107982499A (en) | A kind of Chinese medicine composition and preparation method for being used to treat gout | |
| CN107551243A (en) | A kind of pill medicine and preparation method for treating taste-blindness rate | |
| CN106668525A (en) | Hui-nationality traditional Chinese medicine caterpillar fungus oral solution for treating leukemia and preparation method thereof | |
| CN105770602A (en) | Pharmaceutical preparation for treating esophagus cancer an application of pharmaceutical preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171219 |
|
| RJ01 | Rejection of invention patent application after publication |